Evidence map›Paper›PMID 39287921›Full record

ArticlePharmacoEconomics - open2024

Publisher Correction: Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses.

Fatemeh Mirzayeh Fashami, Jean-Eric Tarride, Behnam Sadeghirad, Kimia Hariri, Amirreza Peyrovinasab, Mitchell Levine

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in PharmacoEconomics - open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Fatemeh Mirzayeh FashamiHealth Research Methodology Graduate Program, McMaster University, 1280 Main St West, Hamilton, ON, Canada. mirzayef@mcmaster.ca.ORCID http://orcid.org/0000-0003-0189-9065
Jean-Eric TarrideCenter for Health Economics and Policy Analysis (CHEPA), McMaster University, 1280 Main St West, Hamilton, ON, Canada.ORCID http://orcid.org/0000-0003-2913-7580
Behnam SadeghiradDepartment of Health Research Methods, Evidence, and Impact, McMaster University, 1280 Main St West, Hamilton, ON, Canada.ORCID http://orcid.org/0000-0001-9422-5232
Kimia HaririFaculty of Pharmacy, Mazandaran University of Medical Science, Sari, Iran.ORCID http://orcid.org/0000-0002-1071-5515
Amirreza PeyrovinasabFaculty of Pharmacy, Islamic Azad University, Tehran Medical Sciences University (IAUTMU), Tehran, Iran.ORCID http://orcid.org/0009-0004-6100-3667
Mitchell LevineDepartment of Health Research Methods, Evidence, and Impact, McMaster University, 1280 Main St West, Hamilton, ON, Canada.ORCID http://orcid.org/0000-0002-9010-0886

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39287921
PMCPMC11499472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.